Phase 1b, Partial-Blind, Parallel Group, Randomized Study to Investigate the Safety and Immunogenicity of a Tetravalent Chimeric Dengue Vaccine (DENVax) Administered Intradermally Using Needle or a Needle-Free PharmaJet Injector in Healthy Adults

Project: Research project

Project Details

StatusFinished
Effective start/end date12/31/12 → 12/6/15

Funding

  • Takeda Vaccines, Inc.: $267,820.00